About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID
Lrp5
low density lipoprotein receptor-related protein 5
MGI:1278315
84 phenotypes from 19 alleles in 18 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background
Annotated Term Reference
Lrp5Gt(OST164883)Lex/Lrp5Gt(OST164883)Lex
involves: 129S5/SvEvBrd
abnormal retinal vasculature morphology J:154863
increased vascular permeability J:154863
vasculature congestion J:154863
Lrp5Gt(OST164883)Lex/Lrp5Gt(OST164883)Lex
involves: 129S5/SvEvBrd * C57BL/6
abnormal bone structure J:133196
abnormal long bone diaphysis morphology J:133196
abnormal lumbar vertebrae morphology J:133196
abnormal trabecular bone morphology J:133196
decreased body weight J:133196
decreased bone mass J:133196
decreased bone mineral density J:133196
decreased bone ossification J:133196
decreased bone resorption J:133196
decreased compact bone mass J:133196
decreased trabecular bone mass J:133196
Lrp5r18/Lrp5r18
C57BL/6J-Lrp5r18
abnormal retinal vasculature morphology J:135279
Lrp5tm1.1Mawa/Lrp5+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N
increased bone mass J:172746
Lrp5tm1.1Mawa/Lrp5tm1.1Mawa
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N
increased bone mass J:172746
Lrp5tm1.1Vari/Lrp5tm1.1Vari
involves: 129S1/Sv
no abnormal phenotype detected J:178499
Lrp5tm1.1Vari/Lrp5tm1.2Vari
Twist2tm1(cre)Dor/Twist2+
involves: 129S1/Sv * 129X1/SvJ
normal skeleton phenotype J:178499
Lrp5tm1.2Vari/Lrp5tm1.2Vari
involves: 129S1/Sv
decreased bone mass J:178499
normal skeleton phenotype J:178499
Lrp5tm1Dgen/Lrp5tm1Dgen
B6.129P2-Lrp5tm1Dgen/J
abnormal b-wave shape J:235600
abnormal retina morphology J:235600
abnormal retinal blood vessel morphology J:235600
abnormal retinal vasculature morphology J:235600
abnormal vascular plexus formation J:235600
abnormal vision J:235600
decreased total retina thickness J:235600
persistence of hyaloid vascular system J:169924, J:235600
Lrp5tm1Dgen/Lrp5tm1Dgen
involves: 129P2/OlaHsd * C57BL/6
abnormal retina morphology J:101679
abnormal retinal layer morphology J:101679
abnormal retinal nerve fiber layer morphology J:101679
abnormal retinal outer nuclear layer morphology J:101679
abnormal retinal outer plexiform layer morphology J:101679
abnormal retinal pigment epithelium morphology J:101679
disorganized retinal inner nuclear layer J:101679
disorganized retinal outer nuclear layer J:101679
disorganized retinal outer plexiform layer J:101679
gliosis J:101679
hypoactivity J:101679
increased thigmotaxis J:101679
retinal degeneration J:101679
retinal ganglion cell degeneration J:101679
retinal photoreceptor degeneration J:101679
thin retinal inner plexiform layer J:101679
thin retinal outer nuclear layer J:101679
thin retinal outer plexiform layer J:101679
Lrp5tm1Grw/Lrp5tm1Grw
involves: 129S1/Sv * 129X1/SvJ
abnormal bone structure J:104382
abnormal osteoblast physiology J:104382
abnormal trabecular bone morphology J:104382
decreased bone mass J:104382, J:213541
decreased bone mineral content J:213541
decreased bone mineral density J:104382, J:213541
decreased bone mineralization J:104382, J:213541
decreased bone ossification J:104382
decreased bone stiffness J:213541
decreased bone strength J:213541
decreased bone volume J:213541
decreased compact bone mass J:213541
decreased osteoblast cell number J:104382
decreased osteoclast cell number J:104382
decreased trabecular bone mass J:213541
osteoporosis J:213541
Lrp5tm1Jfh/Lrp5tm1Jfh
involves: 129S5/SvEvBrd * C57BL/6
abnormal phalanx morphology J:91055
Lrp5tm1Jsak/Lrp5+
involves: C57BL/6 * CBA
decreased circulating insulin level J:81174
impaired glucose tolerance J:81174
increased cholesterol level J:81174
Lrp5tm1Jsak/Lrp5tm1Jsak
involves: C57BL/6 * CBA
abnormal calcium ion homeostasis J:81174
abnormal femur morphology J:81174
abnormal limb morphology J:81174
abnormal liver physiology J:81174
decreased circulating insulin level J:81174
decreased diameter of femur J:81174
decreased diameter of tibia J:81174
decreased insulin secretion J:81174
impaired glucose tolerance J:81174
increased cholesterol level J:81174
increased circulating VLDL cholesterol level J:81174
insulin resistance J:81174
thin parietal bone J:81174
Lrp5tm1Kry/Lrp5+
either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
abnormal bone ossification J:75973
abnormal osteoblast physiology J:75973
decreased bone mass J:75973
decreased bone volume J:75973
delayed bone ossification J:75973
Lrp5tm1Kry/Lrp5+
involves: 129S1/Sv * 129X1/SvJ
increased serotonin level J:146078
Lrp5tm1Kry/Lrp5tm1Kry
either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
abnormal bone ossification J:75973
abnormal eye development J:75973
abnormal osteoblast physiology J:75973
abnormal trabecular bone morphology J:75973
decreased apoptosis J:75973
decreased bone mass J:75973
decreased bone volume J:75973
decreased osteoblast cell number J:75973
delayed bone ossification J:75973
persistence of hyaloid vascular system J:75973
postnatal lethality, incomplete penetrance J:75973
normal skeleton phenotype J:75973
Lrp5tm1Kry/Lrp5tm1Kry
involves: 129S1/Sv * 129X1/SvJ
abnormal bone mineralization J:216098
abnormal retinal vasculature morphology J:135279, J:144980
decreased bone mass J:146078
decreased serotonin level J:146078
increased serotonin level J:146078
persistence of hyaloid vascular system J:101493, J:146078
normal skeleton phenotype J:146078
Lrp5tm1Lex/Lrp5+
involves: 129/Sv * C57BL/6J * FVB/N
abnormal trabecular bone morphology J:111359
decreased bone mineral density J:111359
Lrp5tm1Lex/Lrp5tm1Lex
involves: 129/Sv * C57BL/6J * FVB/N
decreased bone mineral density J:111359
persistence of hyaloid vascular system J:111359
Lrp5tm1Mawa/Lrp5+
involves: 129S1/Sv * 129X1/SvJ
normal skeleton phenotype J:172746
Lrp5tm1Mawa/Lrp5+
Tg(Vil1-cre)997Gum/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL
normal skeleton phenotype J:172746
Lrp5tm1Mawa/Lrp5+
Tg(Prrx1-cre)1Cjt/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL
increased bone mass J:172746
Lrp5tm1Mawa/Lrp5+
Tg(Dmp1-cre)1Jqfe/0
involves: 129S1/Sv * 129S1/SvImj * 129X1/SvJ * FVB/N
increased bone mass J:172746
Lrp5tm2.1Mawa/Lrp5+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N
increased bone mass J:172746
Lrp5tm2.1Mawa/Lrp5tm2.1Mawa
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N
increased bone mass J:172746
Lrp5tm2Kry/Lrp5+
Tg(Vil1-cre)20Syr/0
involves: C57BL/6 * DBA/2
decreased bone mass J:146078
decreased bone ossification J:146078
Lrp5tm2Kry/Lrp5tm2Kry
Tg(Col1a1-cre)1Kry/0
involves: FVB
normal homeostasis/metabolism phenotype J:146078
normal skeleton phenotype J:146078
normal vision/eye phenotype J:146078
Lrp5tm2Kry/Lrp5tm2Kry
Tg(Vil1-cre)20Syr/0
involves: C57BL/6 * DBA/2
abnormal serotonin level J:146078
decreased bone mass J:146078
decreased bone ossification J:146078
decreased osteoblast cell number J:146078
decreased osteoblast proliferation J:146078
normal vision/eye phenotype J:146078
Lrp5tm2Mawa/Lrp5+
involves: 129S1/Sv * 129X1/SvJ
normal skeleton phenotype J:172746
Lrp5tm2Mawa/Lrp5+
Tg(Vil1-cre)997Gum/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL
normal skeleton phenotype J:172746
Lrp5tm2Mawa/Lrp5+
Tg(Prrx1-cre)1Cjt/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL
increased bone mass J:172746
Lrp5tm2Mawa/Lrp5+
Tg(Dmp1-cre)1Jqfe/0
involves: 129S1/Sv * 129S1/SvImj * 129X1/SvJ * FVB/N
increased bone mass J:172746
Lrp5tm3(Lrp5*)Kry/Lrp5tm3(Lrp5*)Kry
Tg(Col1a1-cre)1Kry/0
involves: FVB
normal homeostasis/metabolism phenotype J:146078
normal skeleton phenotype J:146078
Lrp5tm3(Lrp5*)Kry/Lrp5tm3(Lrp5*)Kry
Tg(Vil1-cre)20Syr/0
involves: C57BL/6 * DBA/2
decreased serotonin level J:146078
increased bone mass J:146078
increased bone ossification J:146078
Lrp5tm3.1Mawa/Lrp5tm3.1Mawa
Tg(Dmp1-cre)1Jqfe/0
involves: 129 * C57BL/6J * FVB/N
decreased bone mass J:172746
Lrp5tm3.1Mawa/Lrp5tm3.1Mawa
Tg(Vil1-cre)997Gum/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL
normal skeleton phenotype J:172746
Lrp5tm3.2Mawa/Lrp5tm3.2Mawa
involves: 129S1/Sv
abnormal bone trabecula morphology J:201597
decreased bone mass J:201597
Lrp5tm3.2Mawa/Lrp5tm3.2Mawa
involves: 129S1/Sv * C57BL/6J * FVB/N * SJL
decreased bone mass J:172746
Lrp5tvrm111B/Lrp5tvrm111B
C57BL/6J-Lrp5tvrm111b/Pjn
abnormal blood-retinal barrier function J:241491
abnormal cone electrophysiology J:241491
abnormal retinal neuronal layer morphology J:241491
abnormal retinal vasculature morphology J:241491
decreased a wave amplitude J:241491
decreased areal bone mineral density J:241491
decreased b wave amplitude J:241491
decreased bone mineral content J:241491
persistence of hyaloid vascular system J:241491

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer & Copyright Notice
Send questions and comments to User Support.
last database update
03/31/2020
MGI 6.15
The Jackson Laboratory